Evidence map›Paper›PMID 34016610›Full record

ArticleDiabetes care2021

Response to Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007-3015.

Ian J Neeland, Takatoshi Kasai, Silvio E Inzucchi, Brian S Wojeck, Henry K Yaggi, Odd Erik Johansen, EMPA-REG OUTCOME Investigators

Open access · greenAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Ian J NeelandDivision of Cardiovascular Medicine, Department of Medicine, University Hospitals Harrington Heart and Vascular Institute and Case Western Reserve University School of Medicine, Cleveland, OH ian.neeland@uhhospitals.org.ORCID 0000-0003-2831-3618
Takatoshi KasaiDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Silvio E InzucchiSection of Endocrinology, Yale School of Medicine, Yale University, New Haven, CT.ORCID 0000-0003-1254-6636
Brian S WojeckSection of Endocrinology, Yale School of Medicine, Yale University, New Haven, CT.
Henry K YaggiSection of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, Yale University, New Haven, CT.
Odd Erik Johansen
EMPA-REG OUTCOME Investigators
Yale University · USBoehringer Ingelheim (Norway) · NOJuntendo University · JPUniversity Hospitals of Cleveland · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
Mentoring in Sleep Research and Sleep Interventions in Heart Disease, and StrokeK24HL132093 · NHLBI · YALE UNIVERSITY · PI YAGGI, HENRY KLAR · 2016 to 2020
$336k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS K24 HL132093NIDDK NIH HHS P30 DK045735
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2Sleep Apnea, ObstructiveBenzhydryl CompoundsGlucosidesHumansBenzhydryl CompoundsempagliflozinGlucosides

Identifiers

PMID34016610
PMCPMC8247494
OpenAlexW3163228432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.